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Tubular cellsThe objective of the present study was to investigate the expression and activities of lysosomal enzymes that
act upon proteins and sulfated polysaccharides in diabetic rat kidney. Cathepsins, glycosidases and sulfatases
were studied on the 10th (DM-10) and on the 30th (DM-30) day of streptozotocin-induced diabetes mellitus
(DM). The activity of cathepsin B, the main kidney cysteine protease, was decreased both in DM-10 and
DM-30. Gel ﬁltration chromatography of urinary proteins has shown the prevalence of low molecular weight
peptides in normal and DM-10 urine, in contrast to the prevalence of high molecular weight peptides and in-
tact proteins in DM-30. These results show that the decrease in lysosomal proteases could explain, at least in
part, the increased albuminuria detected by radial immunodiffusion (RID), due to the excretion of less de-
graded or intact albumin. Concerning sulfated polysaccharides, the activities of β-glucuronidase, N-acetyl-
β-D-glucosaminidase, and N-acetyl-β-D-galactosaminidase were also decreased in DM-30, while aryl sulfa-
tases did not vary. Increased toluidine blue metachromatic staining of the tissue suggests that the lower
activities of glycosidases could lead to intracellular deposition of partially digested molecules, and this
could explain the decreased urinary excretion and increased tissue buildup of these molecules. The main
morphological changes observed in kidney were proximal convoluted tubules with thinner walls and thinner
brush border. Immunohistochemistry revealed that most of cathepsin B was located in the brush border of
proximal tubular cells, highlighting the involvement of proximal convoluted tubules in diabetic nephropathy.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Diabetic nephropathy is a serious complication of diabetesmellitus
(DM) and is the most common cause of end-stage renal disease [1]. It
affects approximately one third of patients with type 1 or type 2 DM
[2].
The initial development of diabetic nephropathy in type 1 DM gen-
erally is indicated by microalbuminuria [3]. The changes in albumin
excretion rate have traditionally been attributed to changes in the glo-
merular permselectivity barrier and intraglomerular pressure, with
the assumption that albumin remains intact during ﬁltration and
renal passage [4]. However, studies with 3H-albumin in humans
have shown that 3H-albumin was metabolized to small fragments
during renal passage, and less than 4% of radioactivity was associated
with intact albumin. These fragments were not detected by radioim-
munoassay (RIA), one of the methods traditionally used to reveal
microalbuminuria [5]. In diabetic patients, intact albumin represented
up to 55% of total radioactivity, possibly due to an inhibition of thear, Departamento de Bioquímica,
100, 04044-020, São Paulo, SP,
6407.
.
rights reserved.degradation rate, and this inhibition seems to be directly proportional
to the level of albuminuria detected by RIA [6].
On the other hand, there are evidences suggesting that proximal con-
voluted tubules are important elements for albuminuria in streptozotocin
(STZ)-type 1 diabetic rats. Using ﬂuorescent-labeled albumin and intravi-
tal microscopy, it was shown that diabetic rats presented similar glomer-
ular permeability in the 12thweek,while demonstrating signiﬁcantly less
ﬂuorescent albumin in proximal tubule cells in comparison to non-
diabetic controls [7]. Also, there are evidences indicating that cubilin, a
460 kDa peripheral membrane protein, is essential for albumin
reabsorption by proximal tubule cells, while megalin, a 600 kDa trans-
membrane protein, drives internalization of cubilin-albumin complexes
[8]. The concentration of these two proteins was found to be increased
in the urine of type 1 diabetes+microalbuminuria, suggesting that ab-
normal shedding of megalin and cubilin could contribute to albuminuria
[9].
Other aberrant renal processing in DM concerns sulfated polysac-
charides. We have previously shown a marked decrease in the excre-
tion of urinary glycosaminoglycans in rats with STZ-DM (expressed as
GAGs/24 h), from the second week on [10]. The excretion rate of ex-
ogenous dextran sulfates of different molecular weights was also de-
creased in diabetic rats (10 and 30 days) [11]. In contrast, higher
amounts of dextran sulfates, especially those of high molecular
weights, accumulated in diabetic kidney and liver, suggesting cellular
Table 1
Body weight, kidney weight, and glycemia of rats 10 days and 30 days after induction of diabetes mellitus (streptozotocin) and their matched controls.a
Group Body weight (g) Glycemia (mg/dl) Kidney weight Kidney/body weight
Initial Final Initial 72 h Final (g) (×10−3)
NL-10
(n=13)
308±16 326±19 105±9 106±17 116±28 0.98±0.07 3.09±0.12
DM-10
(n=11)
313±33 282±32⁎ 111±13 424±123⁎ 461±108⁎ 1.26±0.08⁎ 4.09±0.05⁎
NL-30
(n=13)
300±22 325±19 108±13 123±25 108±21 1.01±0.02 3.38±0.05
DM-30
(n=10)
326±28 247±6⁎ 111±10 416±144⁎ 456±81⁎ 1.14±0.06⁎ 4.61±0.18⁎
a The numbers are mean±standard deviation. The groups are as follows: NL-10, controls, 10 days; DM-10, diabetic, 10 days; NL-30, controls, 30 days; DM-30, diabetic, 30 days.
⁎ Pb0.05 vs. Controls.
86 G.B. Peres et al. / Biochimica et Biophysica Acta 1832 (2013) 85–95internalization. The glycosaminoglycan concentration was also in-
creased in diabetic kidney, mainly the glomerulus, due to dermatan
sulfate buildup [9,12].
Renal hypertrophy, with an increase in kidney protein content, is a
well-recognized feature of diabetic nephropathy. This may be the re-
sult of increased protein synthesis and/or decreased degradation.
Olbricht and Geissinger [13] proposed a role for lysosomal proteolytic
enzymes in diabetic renal hypertrophy and reported decreased activ-
ities of cathepsin B and cathepsin L in proximal tubules of STZ-
diabetic rats on the 4th day of diabetes, but these activities were
equal to controls six months later, when end stage renal hypertrophy
had already occurred. A decrease in the tubular cell protein break-
down, with a reduction in the activities of tubular cathepsin B and ca-
thepsin L, was also reported on the 2nd day of diabetes [14]. The
relevance of these proteolytic processes for diabetic nephropathy
has been recently highlighted with the proposition of autophagy,
the lysosomal protein degradation pathway, as a therapeutic target
for diabetic nephropathy [15]. Nevertheless, there are few reports on
the expression and activities of proteolytic enzymes between very
early (2–4 days) and late stages (6 months) of diabetic nephropathy,
and there are even fewer reports concerning lysosomal enzymes that
act upon sulfated polysaccharides, speciﬁcally glycosaminoglycans.
So, the aim of the present study was to investigate the expression
and activities of lysosomal enzymes that act upon proteins and sulfated
polysaccharides – cathepsins, glycosidases and sulfatases – on days 10
and 30 of STZ-type 1 DM in rats. The urinary excretion of proteins and
peptides was also characterized.
2. Materials and methods
2.1. Animals, urine samples, and tissues
The presentworkwas approved by the Ethical Committee of Escola
Paulista de Medicina—UNIFESP (CEP 0170/09), and was carried out in
accordance with UNIFESP guidelines, and also in accordance with ECTable 2
24 h-urine volume, urinary creatinine, total protein, and albumin (measured by radial imm
(streptozotocin) and their matched controls.a
Group Control (NL)
Day 0 10
24 h-urine volume (ml) 7.0±0.9 9.1±1.2
Urinary creatinine (mg/ml) 1.42±0.21 1.31±0.20
Urinary protein (mg/ml) 1.84±0.27 1.86±0.16
Urinary protein (mg/24 h) 12.9±2.7 16.8±2.0
Urinary albumin (RID, mg/24 h) 0.47±0.18 0.66±0.36
Urinary albumin (ELISA, mg/24 h) 1.12±0.37 1.67±0.94
a The numbers are mean±standard deviation.
⁎ Pb0.05 vs. Day 0.Directive 86/609/EEC for animal experiments http://ec.europa.eu/
environment/chemicals/lab_animals/legislation_en.htm.
MaleWistar rats (n=52), 12 weeks of age (275–360 g bodyweight),
were randomly assigned to one of four groups: control, 10 days (NL-10),
diabetes, 10 days (DM-10), control, 30 days (NL-30), diabetes, 30 days
(DM-30). Before the induction of DM, the animals were weighed, blood
glucose was measured (Advantage Kit Roche, Basel, Swiss), and the ani-
mals were placed in metabolic cages for 24 h-urine collection. Diabetes
was induced in the 26 rats of DM groups by a single i.p. injection of STZ
(60 mg/kg body weight). The drug was dissolved in 300 μl of 10 mM so-
dium citrate buffer, pH 4.5. These animals were fed standard laboratory
chow and a 5% glucose solution ad libitum, for 72 h. Afterwards, the glu-
cose solution was replaced by water. The glycemia was measured 72 h
after STZ administration, and also at the end of each experiment (either
10th or 30th day). Only animals that, at 72 h, presented blood glucose
higher than 250 mg/dl were considered “diabetic” [16]. The 26 age-
matched animals that served as controls (NL-10 and NL30) received
only buffer (300 μl) and were fed standard laboratory chow and water
ad libitum.
At the end of each experiment, the body weight was again deter-
mined, and the ratswere placed inmetabolic cage for 24 h-urine collec-
tion. The 24 h-urine volume was measured, the urine was centrifuged
to remove debris, and used for determination of creatinine, total pro-
tein, and albumin. Creatinine was quantiﬁed by the picric acid reaction
in alkaline conditions (CELM creatinine kit, São Paulo, SP, Brazil); total
protein wasmeasured by the pyrogallol red-molybdate complexmeth-
od (Sensiprot, Labtest, Lagoa Santa, MG, Brazil) [17]; albumin was de-
termined by two methods: (1) radial immunodiffusion (RID) based
on precipitation with rabbit antibodies against rat albumin [10],
and (2) ELISA with Bethyl E110-125 Rat Albumin Quantiﬁcation
Set (Montgomery, TX, USA).
After urine collection, the rats were euthanized, both kidneys were
removed, weighed, and carefully cut in small fragments (~100 mg
each). These fragmentswere used for RNA extraction (Section 2.3), mea-
surement of enzyme activities (Section 2.4), Western blotting andunodifusion, RID, and by ELISA) on days 0, 10 and 30 after diabetes mellitus induction
Diabetes mellitus (DM)
30 0 10 30
8.0±2.1 6.8±1.2 97.0±8.4⁎ 84.6±11.9⁎
1.23±0.22 1.66±0.29 0.21±0.03⁎ 0.21±0.03⁎
1.80±0.65 1.89±0.36 0.22±0.08⁎ 0.45±0.12⁎
13.6±2.9 12.8±2.2 20.5±5.9⁎ 37.9±11.0⁎
0.48±0.23 0.46±0.23 0.89±0.19⁎ 2.50±1.59⁎
1.31±0.70 1.04±0.56 2.03±0.60⁎ 7.38±2.31⁎
Fig. 1. Gel ﬁltration chromatography of urinary proteins. Urine samples from normal (NL) and diabetic (DM-10 and DM-30) rats were applied to a Sephadex G-100 Superﬁne column
(1×30 cm), equilibrated and eluted with PBS. Fractions (0.72 ml) were collected at a ﬂow rate of 0.12 ml/min. Panel (A) shows the protein proﬁles (BCA, A562); panel (B) shows the
SDS–PAGE (12%) of aliquots (10 μl) of selected fractions (2, 4, 6, 8, 9, 10, 11, 12, 14), stained by silver nitrate in alkaline medium; panel (C) shows Western blotting revealed for rat
albumin of NL and DM-30 urine samples. Molecular weight markers are also shown.
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put in sterile tubes, frozen in liquid nitrogen, and stored at −70 °C
until use.
2.2. Gel ﬁltration chromatography and Western blotting
The molecular weight of urinary proteins was estimated by gel ﬁl-
tration chromatography. Urine samples (0.5–2 ml) were applied to a
column (1×30 cm) of Sephadex G-100 Superﬁne, equilibrated and
eluted with PBS (0.1 ml/min). The collected fractions (0.72 ml each)
were analyzed for creatinine and protein.
Protein was quantiﬁed in the tissue extracts and also in the Sephadex
G-100 eluted fractions by amodiﬁed Lowryprocedurewith bicinchoninic
acid [18] (BCA Protein Kit Assay, Pierce, IL, USA), using bovine serum al-
bumin as standard. Urinary protein was measured by the pyrogallol
red-molybdatemethod because creatinine interfereswith the BCAmeth-
od. BCA was used to measure proteins in Sephadex G-100 fractions be-
cause it detects both intact proteins and peptides. Aliquots (10 μl) of
the protein-containing fractions were submitted to SDS–PAGE (12%),
stained with silver nitrate in alkaline medium [19], and also revealed by
Western blotting for albumin (Bethyl A110-134P, 1:10,000).
Western blotting was also used to test the speciﬁcity of anti-
cathepsin B and anti-β-actin antibodies, as previously described [20].
In brief, after SDS–PAGE of tissue extracts, proteins were transferred
to nitrocellulose membranes (Millipore, Billerica, MA, USA). After
blocking (2% casein in Tris-buffered saline containing 0.05% Tween
20—TBST), membranes were probed with either rabbit polyclonal
anti-cathepsin B antibody (1:250, Cat. No. 06-480, Millipore) or rabbit
monoclonal anti-β-actin antibody (1:500) in 1% bovine serumalbumin (BSA) in TBST. Then, the membranes were washed with
TBST and incubated with peroxidase-conjugated goat anti-rabbit IgG
secondary antibody (1:3,000, Millipore). The antibody bindingwas vi-
sualized ﬁrst through chemiluminescent substrate (ECL Advance
Western Blotting Detection Kit, GE Healthcare, Piscataway, NJ, USA),
and then tetramethylbenzidine (KPL, Gaithersburg, MD, USA). Images
were obtained in MF-ChemiBIS gel documentation system (DNR Bio
Imaging Systems Ltd., Jerusalem, Israel) with the software GelCapture
7.0.6 for Windows™.
2.3. RNA extraction, analysis, and qPCR
Each tissue fragment (~100 mg) was disrupted in liquid nitrogen,
homogenized in 1 ml of QIAzol Lysis Reagent (QIAGEN Inc., CA,
USA), and processed according to the manufacturer's instructions
(QIAzol® Handbook, Sample and Assay Technologies, 2009). A260/280
and A260/230 were measured (ND-1000, NanoDrop, Delaware, USA),
and samples with ratios lower than 1.8 and 1.7, respectively, were
discarded. The integrity of RNA was also evaluated through 28S and
18S rRNA bands in agarose gel electrophoresis, Tris-borate-EDTA buff-
er, as previously described [21,22]. To avoid contaminationwith geno-
mic DNA, RNA samples were treated with DNase I (Fermentas
International, Inc., Ontario, Canada, 1 unit per μg of RNA, 30 min,
37 °C) followed by 25 mM EDTA (1 μl/enzyme unit, 10 min, 65 °C),
to inactivate DNase I.
One microgram of RNA was reverse-transcribed to complementa-
ry DNA (cDNA) with RevertAid M-MuLV (Fermentas International,
Inc., Ontario, Canada). The resulting single-strand cDNA was ampli-
ﬁed by qPCR in a reaction mixture containing 0.4 μM of each primer
Fig. 2. Expression (mRNA) of cathepsin B, cathepsin L, and β-D-glucuronidase in diabetic (DM) and normal (NL) rat kidney. The expression of mRNA was normalized either by ribosomal
protein S29 (RPS29) or β-actin (ACTB). The expression of RPS29 varied in diabetes relative to ACTB, indicating that it is not a good housekeeping gene in DM. Data representmean±standard
deviation. Statistically signiﬁcant differences between NL and DM are shown as Pb0.05.
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ﬁnal volume). The thermal cycling conditions were as follows: initial
5 min at 95 °C, followed by 40–45 cycles of denaturing at 95 °C for
5 seconds, annealing at 60 °C for 10 seconds, and extension at 95 °C
for 10 min. Cycle number and cDNA concentration were adjusted so
that ampliﬁed products remained within the linear range of the PCR
reaction. PCR ampliﬁcation was conducted on a Corbett Rotor-Gene
6000 (QIAGEN, Inc., CA, USA). Each PCR was done in duplicate.
Relative gene expression was calculated by the 2−ΔΔCT method
developed by Livak and Schmittgen [23]. In this method, it is assumed
that the expression of a reference gene (housekeeping gene) is inde-
pendent of external factors and that its expression is quite constant.
In the present paper, two genes were used as references: ribosomal
protein 29S (RPS29) and β-actin (ACTB).
The PCR primers (Bioneer Corporation, Alameda, CA, USA) were as
follows: cathepsin B, forward 5′ GCTATCCCTCTGGAGCATGGAAC 3′,
and reverse, 5′ GACGGGAGCCATTGACATGGT 3′; cathepsin L, forward
5′ AGGCAATCAGGGCTGTAATGGAG 3′, and reverse, 5′ CGTTAGCCACAGCATACTCAGCTC 3′; β-glucuronidase, forward 5′ CAGTGCTTCCACA
GCGATGGA 3′, and reverse 5′ GTGATGTCAGCCTCAAAGGGGAG 3′,
β-actin forward 5′ GGATGACGATATCGCTGCGCT 3′, and reverse 5′ C
TGACCCATACCCACCATCACAC 3′, and S29 ribosomal protein forward
5′ GTCAGTACGCGAAGGACATAGGC 3′, and reverse 5′ CAGGGTAGAC
AGTTGGTTTCATTGGG 3′.
2.4. Enzyme activities
Tissue samples (~100 mg) were disrupted in liquid nitrogen, and
resuspended in 1 ml of 50 mM Tris–HCl buffer, pH 7.4, containing
200 mM NaCl and 250 mM sucrose [24] plus 1 ml of 0.2% Triton
X-100. After standing for 10 min in an ice bath, debris was removed
by centrifugation (12,000 ×g, 10 min, 4 °C). Aliquots of the superna-
tant (100 μl) were stored in sterile tubes at −70 °C until use (tissue
extracts).
Protease activities were quantiﬁed by ﬂuorometric assays using ei-
ther carbobenzoxy-Phe-Arg-7-amide-4-methylcoumarin (Z-FR-MCA,
Fig. 3. Kinetics of cysteine protease activities in diabetic (DM) and normal (NL) rat kidney. (A) Standard curve of free 7-amino-4-methylcoumarin (MCA), showing the linearity range.
Tissue extracts (1–3 μl containing 10 μg of protein) were incubated with either 20 μM Z-FR-MCA (B), and 20 μM ε-NH2-caproyl-Cys(Bzl)-Cys(Bzl)-MCA (C) (200 μl ﬁnal volume). A
maximum of 10% substrate consumption was considered, and each point represents mean±95% conﬁdence interval of four replicates for all animals in each group. The presence of
PMSF did not affect the total protease activities. Inhibitor concentrations: PMSF=1 mM; CA074=1 μM; E64=5 μM.
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Cys(Bzl)-MCA (synthesized by Prof. Dr. Maria A. Juliano) [25], as sub-
strates. These substrates were used to quantify total cysteine-proteasesand cathepsin B, respectively. The incubations were carried out in dark
microplates (Corning, MA, USA), in 50 mM phosphate buffer, pH 6.3,
containing 10 mM EDTA. The enzymes (10 μg of protein) were
Fig. 4. Speciﬁc activities of cysteine proteases in diabetic (DM) and normal (NL) rat kidney. The assays were performed as described in Fig. 3, except that speciﬁc activities are shown
(pmol/min/μg of protein). Data represent mean±standard deviation. Statistically signiﬁcant differences between NL and DM are shown as Pb0.05.
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dithiothreitol (DTT, 10 min, room temperature), and then the substrate
was added (20 μM, 200 μl ﬁnal volume). The ﬂuorescence produced
upon hydrolysis of the substrates was measured every 20 seconds in
FlexStation 3 (Molecular Devices, CA, USA), using λexcitation=380 nm
and λemission=460 nm. The assays were also performed in presence
of inhibitors: 1 mM phenylmethylsulfonyl ﬂuoride (PMSF, inhibitor
of serine-proteases), 5 μM E64 (irreversible inhibitor of cysteine-
proteases) and 1 μM CA074 (irreversible inhibitor of cathepsin B).
The activities of β-D-glucuronidase, N-acetyl-β-D-glucosaminidase,
N-acetyl-β-D-galactosaminidase, and sulfatases, were measured by
spectrophotometric assays using the following substrates, respec-
tively: 4-nitrophenyl β-D-glucuronide, 4-nitrophenyl N-acetyl-β-D-
glucosaminide, 4-nitrophenyl N-acetyl-β-D-galactosaminide, and
4-nitrophenyl sulfate (Sigma-Aldrich Corp., St. Louis, MO, USA). All
assays were performed in microplates, always as triplicates, and
the incubation mixtures (150 μl ﬁnal volume) contained 50 mM so-
dium acetate buffer, pH 5.0, 2 mM substrate and increasing amounts
of tissue extracts (2–30 μl containing 20–120 μg of protein). After
1 h incubation at 37 °C, the 4-nitrophenol released was solubilized
by addition of 1 MNaOH (150 μl), and the absorbancewasmeasured
immediately at λ405 in a microplate reader (Molecular Devices, CA,
USA).
2.5. Histology and immunohistochemistry
For histology and immunohistochemistry, one rat of each group
was anesthetized with 10% chloral hydrate (4 ml/kg body weight),
and perfused with ﬁltered saline (150 ml, 12 ml/min) followed by4% formalin in 0.1 M phosphate buffer, pH 7.4 (500 ml, 12 ml/min).
The kidneys were removed, cut, dehydrated, embedded in parafﬁn,
and cut in 4 μm sections. These sections were transferred to silane-
coated microscope slides and dewaxed as previously described [26].
Kidney sections were stained with either hematoxylin and eosin
(H&E) or toluidine blue, and images were obtained with a Zeiss Axiolab
microscope (Carl Zeiss MicroImaging GmbH, Göttingen, Germany),
equippedwith AxioCamMRCdigital camera and the software AxioVision.
For immunohistochemistry, the dewaxed slideswere transferred into
200 ml of pre-warmed 10 mM sodium citrate buffer, pH 6.0 (95 °C). An-
tigen retrieval was 30 min at 95 °C, 20 min on the bench, and 5 min in
running water. Endogenous peroxidase was blocked by 3% hydrogen
peroxide (10 min, 10 times), followed by running water (10 min) and
phosphate buffered saline (PBS, 3 min, 3 times). Unspeciﬁc protein bind-
ing was blocked by 200 μl of 1% bovine serum albumin (BSA, Cat. No.
A3059, Sigma-Aldrich, St. Louis, MO, USA) and 2% fetal calf serum in
PBS in a moist chamber at room temperature. The primary antibody
was rabbit anti-cathepsin B (Cat. No. 06-480, EMD Millipore, Billerica,
MA, USA) diluted 1:100 in blocking solution. After overnight incubation
at 4 °C and 3×5 minwashes in PBS, secondary antibody goat anti-rabbit
IgG, HRP-conjugate (Cat. No. 12-348, EMDMillipore, Billerica, MA, USA)
diluted 1:200 in blocking solutionwas added. After 90 min and 3×5 min
washes in PBS, nickel enhanced diaminobenzidine (Cat. No. 54-74-00,
HistoMark Orange Peroxidase System, KPL, Inc., Gaithersburg, MD,
USA) was used as HRP substrate. After running water, the tissues were
counterstained by hematoxylin solution, Harris modiﬁed (Cat. No.
HHS16, Sigma-Aldrich, St. Louis, MO, USA), 30 sec. The excess of hema-
toxylin was removed by 0.1% HCl in 70% ethanol, followed by 5 min in
running water. Slides were dehydrated and mounted in Entellan (Cat.
Fig. 5. Speciﬁc activities of glycosidases and sulfatases in diabetic (DM) and normal
(NL) rat kidney. Tissue extracts (2–30 μl containing 20–120 μg of protein) were incu-
bated with either p-nitrophenil monosaccharides or p-nitrophenil sulfate. Results are
given as mean±standard deviation. Statistically signiﬁcant differences between NL
and DM are shown as Pb0.05.
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ish. Negative controls were incubated with blocking solution, at each
step.2.6. Statistical analysis
Statistical analysis was performed using PASW Statistics (SPSS Sta-
tistics) for Windows™ (version 18.0.0). Data were evaluated for nor-
mality by the Shapiro–Wilk test, and were standardized (z-score)
when the parametric distribution was not observed. Bootstrap, aresampling method, was also used to check for the stability of the ex-
perimental data. Results are presented as mean±standard deviation,
except for enzyme kinetics, when mean±95% conﬁdence interval is
shown. Differences between groups were analyzed by ANOVA. Values
of Pb0.05 were considered signiﬁcant.
3. Results
3.1. Glycemia, body weight, kidney weight, 24-h urine volume, urinary
creatinine, total protein, and albuminuria
Table 1 shows that 10 days and 30 days after STZ injection most of
the experimental rats presented increased blood glucose concentra-
tions. Two animals of the DM-10 group did not become diabetic and
were excluded, and three animals of the DM-30 group died before
the end of the experimental period. In contrast to the control animals
(NL-10 and NL-30), which gained weight, all the diabetic rats have
shown a progressive and signiﬁcant decrease in body weight. In
contrast, the kidney weight increased in diabetic rats, as well as the
kidney/body weight ratios.
Table 2 shows the 24 h-urine volume, and the concentrations of cre-
atinine (colorimetric, picric acid reaction), total protein (measured by the
pyrogallol red-molybdate complex colorimetric method), and albumin
(measured by RID and ELISA). As expected, the urine volume increased
and the creatinine concentration decreased in diabetic animals. The pro-
tein concentration also decreased in the urine (expressed as mg/ml), but
24 h protein excretion increased. Urinary albumin also signiﬁcantly and
progressively increased. Although different values were obtained by RID
and ELISA, the correlation coefﬁcient of the two methods was very high
(R2=0.9947).
3.2. Urinary proteins
Urine samples were submitted to gel ﬁltration chromatography in
Sephadex G-100, and the eluted fractions were analyzed for creati-
nine and total protein (Fig. 1-A). Aliquots of the fractions were also
submitted to SDS–PAGE (silver staining, Fig. 1-B) and Western blot-
ting for albumin (Fig. 1-C). In normal urine, there was a prevalence
of low molecular weight peptides, which were revealed by BCA reac-
tion and SDS–PAGE-silver staining, although intact albumin was also
present (Western blotting). Similar results were obtained for DM-10
urine samples. In contrast, in the urine of rats that remained diabetic
for 30 days (DM-30), a prevalence of high molecular weight peptides
and proteins occurred.
3.3. Quantitative PCR (qPCR) for cathepsin B, cathepsin L and
β-glucuronidase
Two housekeeping genes—ribosomal protein S29 (RPS29) and
β-actin (ACTB) were included in the qPCR analysis, and the results
obtained for 2−ΔΔCT is shown in Fig. 2. The expression of RPS29 de-
creased in diabetes-30 days relative to ACTB, indicating that at least
one of them is not a good housekeeping gene. Relative to RPS29, an
apparent increase of lysosomal enzymes was observed on DM-30. In
contrast, no changes occurred in the expression of cathepsin B
when the expression was normalized by ACTB, while a signiﬁcant de-
crease in the relative expression of cathepsin L (10 days) and
β-glucuronidase (10 days and 30 days) occurred.
3.4. Activities of lysosomal enzymes
The kinetics of formation of ﬂuorescent product from two differ-
ent substrates – Z-FR-MCA and ε-NH2-caproyl-Cys(Bzl)-Cys(Bzl)-
MCA – are shown in Fig. 3, either with or without inhibitors
(PMSF, CA074 and E64). PMSF inhibits serine-proteases, E64 in-
hibits cysteine-proteases, and CA074 inhibits only cathepsin B.
Fig. 6. Optical microscopy of diabetic (DM) and normal (NL) rat kidneys. Tissue samples from normal and diabetic kidneys (10 days and 30 days of diabetes) were included in parafﬁn, cut
in 4 μmsections, and stainedwithH&E. Lowmagniﬁcation images (bars=100 μm) show cortical region,with convoluted tubules andglomeruli. Arrow indicates stroma among convoluted
tubules in DM cortex (30 days). Higher magniﬁcation images (bars=20 μm) of glomeruli and tubules are also shown.
92 G.B. Peres et al. / Biochimica et Biophysica Acta 1832 (2013) 85–95PMSF had no effect upon enzymatic activities on the substrates here
used, and no enzyme activities were detected in presence of E64, in-
dicating that only cysteine-proteases were acting upon the sub-
strates. Z-FR-MCA was substrate for cathepsin B and also other
cysteine-proteases, while ε-NH2-caproyl-Cys(Bzl)-Cys(Bzl)-MCA
was substrate for cathepsin B only.
Fig. 4 shows that cathepsin B was the main cysteine protease pres-
ent in rat kidney, both normal and diabetic. A decrease in cathepsin B
speciﬁc activities occurred in diabetic kidneys, both on the 10th and
on the 30th days. No changes were observed for other cysteine-
proteases (resistant to CA074, Z-FR-MCA as substrate).
Concerning lysosomal glycosidases, a decrease in the speciﬁc activities
was observed for β-D-glucuronidase, N-acetyl-β-D-glucosaminidase, and
N-acetyl-β-D-galactosaminidase only on the 30th day of diabetes. In con-
trast, the speciﬁc activities of aryl sulfatases did not vary (Fig. 5).3.5. Histology of diabetic kidney
Fig. 6 shows that, in diabetic kidney, the tubular lumen was in-
creased, both on the 10th and on the 30th days, with thinner walls
and increased stroma. The brush border of proximal convoluted tu-
bules was also thinner, in comparison to normal controls.
Toluidine blue staining (Fig. 7) shows nucleus (blue) and proteo-
glycans (metachromatic, purple). A higher intensity of metachromat-
ic staining appeared in diabetic tubules, especially at the 30th day, in
comparison to controls.
3.6. Western blotting and immunohistochemistry of cathepsin B
Fig. 8 shows that the expected bands of pro-cathepsin B (~40 kDa)
and native cathepsin B (26 and 30 kDa) were detected by Western
Fig. 7. Optical microscopy of diabetic (DM) and normal (NL) rat kidney stained by toluidine blue. The experiment was performed as described in Fig. 6, except that the kidney sections
were stained by toluidine blue. Arrows indicate metachromatic staining. Bars=20 μm.
93G.B. Peres et al. / Biochimica et Biophysica Acta 1832 (2013) 85–95blotting, indicating the antibody speciﬁcity. As a control, the Western
blotting of β-actin is also shown.
Immunohistochemistry for cathepsin B is shown in Fig. 9. Strong
labeling appeared in the brush border of proximal convoluted tubules,
especially for diabetic kidney.
4. Discussion
The present paper reports decreased activities of lysosomal en-
zymes on the 10th and the 30th days of DM. It also shows that, in con-
trast to normal and early DM (10 days), on the 30th day of DM a
prevalence of high molecular weight peptides and proteins appeared
in the urine, indicating the excretion of less digested proteins.
Althoughmicroalbuminuria, which is considered the earliest man-
ifestation of diabetic nephropathy, has been traditionally attributed toFig. 8. Representative Western blottings of cathepsin B and β-actin extracted from diabetic (D
submitted to SDS–PAGE (12% acrylamidewith 0.32% bisacrylamide for cathepsin B; 7.5% acrylam
branes for Western blottings probed with either rabbit polyclonal anti-cathepsin B or rabbit
(anti-rabbit IgG) conjugatedwith horseradish peroxidase (HRP) and ECL-chemiluminescent sub
resents a pool of four animals of each group.changes in the glomerular permselectivity barrier, Comper et al. have
published a series of papers suggesting that the glomerular ﬁltration
barrier is more leaky to albumin than previously accepted [27]. It
was shown that, in normal kidney, albumin is internalized by endocy-
tosis in proximal tubule cells, digested in lysosomes to low molecular
weight fragments, and returned to the tubular lumen [28]. Our results
on urinary proteins and albumin are in agreement with this idea.
In 2001, using FITC-labeled albumin Tojo et al. have shown that, in
the early stages of diabetes mellitus (2 weeks), tubular reabsorption
of albumin was decreased in the proximal tubule of diabetic rats via
a decrease in endocytosis of albumin associated with decreased ex-
pression of megalin [29]. Furthermore, it was shown that the degra-
dation of reabsorbed proteins is inhibited in the proximal tubule of
diabetes, via decreased cathepsin B and L activity in lysosomes [5,6].
In 2003, it was shown that angiotensin II blockage restored albuminM) and normal (NL) rat kidney. Tissue extracts (3–5 μl containing 30 μg of protein) were
idewith 0.2% bisacrylamide for β-actin). Proteinswere transferred to nitrocellulosemem-
monoclonal anti-β-actin antibody. Speciﬁc bands were detected by secondary antibody
strate. Images were obtainedwithMF-ChemiBIS gel documentation system. Each lane rep-
Fig. 9. Immunohistochemistry of cathepsin B in diabetic (DM) and normal (NL) rat kidneys. Tissue sections were incubated with primary rabbit polyclonal anti-cathepsin B antibody.
Anti-rabbit IgG conjugatedwith HRPwas used as secondary antibody, and nickel enhanced diaminobenzidine was used as HRP substrate. Tissues were counterstainedwith hematoxylin
solution (bars=20 μm).
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abetes [30]. In 2011, the colocalization of cathepsin B and Alexa-bovine
serum albumin (BSA) in proximal convoluted tubules of normal mice
was reported [31]. The same authors have also shown that the intrinsic
lysosomal protein Limp-2 (the murine homolog of human SCARB2)
plays a role in the fusion of endosomes containing reabsorbed proteins
to lysosomes. The megalin/cubilin-dependent uptake of injected
Alexa-BSA in Limp-2-deﬁcient mice was similar to normal, but
Alexa-BSA persisted in proximal convoluted tubule, and did not
colocalize with cathepsin B [31]. Nevertheless, there is no evidence of
impaired expression/function of SCARB2/Limp-2 in DM, suggesting
that the lower than normal protein digestion here reported is due to de-
creased lysosomal enzyme activities (mainly cathepsin B) and/or de-
creased megalin/cubilin-dependent protein uptake, not to decreased
endosome/lysosome fusion.
Additionally, decreased urinary excretion of GAGs occurred. Meta-
chromatic staining of tubular cells by toluidine blue suggested build up
of GAGs. The activities of all the lysosomal glycosidases here studied –
β-D-glucuronidase, N-acetyl-β-D-glucosaminidase, and N-acetyl-β-D-
galactosaminidase – were decreased on the 30th day of DM. Although
no changes in sulfatase activities were observed in our experimen-
tal model, decreased sulfatases in DM isolated glomeruli have
been previously reported [32]. Experimental evidences suggest
that sulfated polysaccharides are ﬁltered and internalized by kidneycells, although the receptor has not yet been characterized. In DM,
due to a lower digestion rate, these compounds accumulate in the
tissue (see references [10] for GAGs and [11] for dextran sulfate),
possibly in proximal tubule cells as well.
We have previously reported that mesangial cells isolated from long
term diabetes mellitus (rats) synthesize and secrete increased amounts
of dermatan sulfate proteoglycans, proportional to the time of disease
[33]. These proteoglycans are supposed to be deposited in themesangial
extracellular matrix. Now, we report an increase in tubular cell meta-
chromatic staining. The decreased activity of lysosomal enzymes could
lead to intracellular accumulation of partially digested macromolecules
(including proteoglycans), and these engorged endosomes could impair
tubular cell function in many ways, including endocytosis, shedding of
receptors, thinning of brush border, etc.
Concerning the expression of cathepsin B and β-glucuronidase
accessed by qPCR, different results were obtained relative to the
two reference genes here used. Relative to ACTB, the expression of ca-
thepsin B did not vary and β-glucuronidase decreased in DM, while
relative to RPS29, an apparent increase occurred on the 30th day
(DM-30). Nevertheless, the expression of RPS29 decreased relative
to ACTB, indicating that at least one of them is not a good housekeep-
ing gene. As Western blotting did not show any important increase
(or decrease) in cathepsin B concentration (protein), and the enzyme
activities decreased in diabetic kidney, we considered ACTB as a better
95G.B. Peres et al. / Biochimica et Biophysica Acta 1832 (2013) 85–95reference gene. Other gene commonly used as reference is GAPDH
(glyceraldehyde 3-phosphate dehydrogenase), but its expression
also varies in diabetes [34,35], and could not be used.
The main morphological changes observed in kidney were proxi-
mal convoluted tubules with thinner walls and thinner brush border.
Immunohistochemistry staining has shown that most of the rat kid-
ney cathepsin B occurred in proximal convoluted tubules. The strong
staining observed in diabetic tubules should be due to higher antigen
concentration due to brush border thinning. Nevertheless, an in-
creased expression of cathepsin B on the 30th day is also possible, po-
tentially trying to counteract the decreased activity, although no
increase has been observed in Western blotting (see Fig. 8).
Taken together, these results show that the decreased lysosomal
protease activities could explain, at least in part, the increased albumin-
uria detected by RID, due to the excretion of less degraded albumin.
If the decrease in lysosomal enzymes here reported reﬂects a general
lysosomal failure, it is possible that the lysosome-mediated autophagy,
which has been recently recognized to play a renoprotective role under
several conditions, could be deﬁcient. This autophagy deﬁciency in dia-
betic kidney couldmake tubular cells fragile under stress, possibly leading
to progression of diabetic nephropathy [15].Acknowledgments
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